Cori cycle

Cori cycle The Cori cycle describes the metabolic pathway by which lactate produced in skeletal muscle is transported to the liver for conversion to glucose and returned to muscle for energy, linking anaerobic glycolysis and gluconeogenesis. Proposed in the 1920s by Gerty Cori and Carl Ferdinand Cori, the cycle unites observations from biochemistry research, clinical studies in diabetes mellitus, and physiological experiments on exercise and hypoxia. It remains central to understanding energy metabolism in contexts studied by institutions such as the National Institutes of Health, Max Planck Society, and Johns Hopkins University.

Overview and Historical Background

The concept emerged from experiments by Gerty Cori and Carl Ferdinand Cori at the Washington University in St. Louis and later at the Rockefeller University, where investigations of carbohydrate metabolism integrated findings from studies on glycogen and lactic acid in muscle and liver. The Coris' work intersected with contemporaneous efforts by researchers at the Pasteur Institute and researchers influenced by the Royal Society meetings, contributing to their receipt of the Nobel Prize in Physiology or Medicine. Subsequent investigators at institutions such as the University of Cambridge, Harvard Medical School, and Karolinska Institute expanded the framework to include hormonal control, linking to discoveries about insulin, glucagon, and stress responses characterized by studies from Cleveland Clinic and Mayo Clinic.

Biochemical Pathway and Mechanism

At its core, the cycle couples anaerobic glycolysis in skeletal muscle—where hexokinase, phosphofructokinase, and pyruvate kinase catalyze conversion of glucose to pyruvate and then to lactate via lactate dehydrogenase—with hepatic gluconeogenesis orchestrated by enzymes including pyruvate carboxylase, phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase. Lactate transport uses monocarboxylate transporters characterized in studies at the Salk Institute and Max Planck Institute for Molecular Physiology, enabling shuttling through the bloodstream to the hepatic portal vein and back as glucose via the systemic circulation, supplying muscles during continuous activity. Energetically, the cycle involves ATP and NADH cofactors, with hepatic gluconeogenesis consuming ATP equivalents tracked in metabolic flux analyses by groups at Massachusetts Institute of Technology and ETH Zurich.

Physiological Role and Regulation

Physiologically, the pathway supports anaerobic ATP generation during high-intensity exercise studied by researchers at Stanford University, facilitating temporary maintenance of muscle function until aerobic metabolism via mitochondria predominates. Hormonal regulation involves inhibitory and stimulatory signals from insulin and glucagon respectively, integrating with stress mediators such as epinephrine and pathways elucidated by laboratories at the National Institutes of Health and Imperial College London. Tissue-specific expression of transporters and enzymes, influenced by transcription factors examined at Cold Spring Harbor Laboratory and the University of California, San Francisco, modulates flux according to nutritional state, hypoxia-inducible factors described by work at the Karolinska Institute affect activity under low-oxygen conditions, and adaptations seen in endurance athletes have been profiled by teams at Australian Institute of Sport and University of Queensland.

Clinical Significance and Disorders

Clinically, perturbations of the pathway are implicated in lactic acidosis encountered in sepsis, mitochondrial diseases, and drug-induced states investigated in case series from Johns Hopkins Hospital and Mayo Clinic. In type 2 diabetes mellitus, altered hepatic gluconeogenesis contributes to hyperglycemia, a topic central to trials at Oxford University and University College London assessing inhibitors of gluconeogenesis and modulators of insulin sensitivity. Tumor metabolism, characterized by the Warburg effect and studied extensively at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, leverages lactate shuttling influencing tumor microenvironment and metastasis. Therapeutic approaches emerging from collaborations involving Pfizer, Roche, and academic centers target monocarboxylate transporters and regulatory enzymes to modulate lactate flux in conditions ranging from exercise intolerance described at Cleveland Clinic to inherited defects catalogued by Orphanet and national rare-disease registries.

Comparative and Evolutionary Perspectives

Comparative studies in organisms including Drosophila melanogaster, Caenorhabditis elegans, and Danio rerio have elucidated conserved aspects of lactate metabolism and transporter evolution, with evolutionary genomics contributions from research groups at Broad Institute and European Molecular Biology Laboratory. In vertebrate physiology, adaptations in diving mammals such as the Weddell seal and in high-altitude populations like researchers studying Tibetan Plateau residents reveal modifications in lactate handling consistent with selection pressures explored by teams at Smithsonian Institution and University of Alaska Fairbanks. Microbial and plant biochemistry studies at Max Planck Institute for Biology and University of California, Berkeley provide contrasts in carbon flux strategies, informing synthetic biology projects at MIT and ETH Zurich that repurpose lactate pathways for biofuel and bioproduct production.

Category:Metabolism